Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
STAAR Surgical Company
STAA
$20.51
Name : STAAR Surgical Company
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $1,028,453,120.00
EPSttm : 0.08
finviz dynamic chart for STAA
STAAR Surgical Company
$20.51
7.49%
$1.43
STAA — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

15.27

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.09

EPS Last/This Y

2.38

EPS This/Next Y

0.26

Price

20.49

Target Price

27.89

Analyst Recom

2.82

Performance Q

-29.98

Upside

-88.1%

Beta

1.19

Ticker: STAA




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28STAA22.110.412.4510923
2026-08-31STAA22.610.410.2710880
2026-09-02STAA23.130.410.7910878
2026-09-03STAA23.570.413.6010886
2026-09-04STAA23.50.410.1210851
2026-09-08STAA24.150.410.3810918
2026-09-09STAA23.610.410.2910916
2026-09-10STAA23.410.410.1510918
2026-09-11STAA22.660.410.2710943
2026-09-14STAA23.070.410.0410955
2026-09-15STAA22.450.400.6711145
2026-09-16STAA22.40.400.0811149
2026-09-17STAA21.230.390.9211011
2026-09-18STAA20.830.380.6610999
2026-09-21STAA20.330.610.286761
2026-09-22STAA20.620.610.206810
2026-09-23STAA19.790.600.196912
2026-09-24STAA19.360.590.666942
2026-09-25STAA20.490.580.096923
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28STAA22.07-64.5- 0.76
2026-08-31STAA22.60-64.5- 0.76
2026-09-01STAA23.52-64.5- 0.76
2026-09-02STAA23.13-64.5- 0.76
2026-09-03STAA23.61-64.5- 0.76
2026-09-04STAA23.50-64.5- 0.76
2026-09-08STAA24.17-64.5- 0.76
2026-09-10STAA23.43-64.5- 0.76
2026-09-11STAA22.66-64.5- 0.76
2026-09-14STAA23.06-64.5- 0.76
2026-09-15STAA22.45-64.5- 0.76
2026-09-16STAA22.45-64.5- 0.76
2026-09-17STAA21.23-64.5- 0.76
2026-09-18STAA20.83-64.5- 0.76
2026-09-21STAA20.34-64.5- 0.76
2026-09-22STAA20.62-64.5- 0.76
2026-09-23STAA19.79-64.5- 0.76
2026-09-24STAA19.08-64.5- 0.76
2026-09-25STAA20.49-64.5- 0.76
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28STAA3.47-0.6814.55
2026-08-31STAA3.47-0.9214.55
2026-09-01STAA3.47-0.9214.55
2026-09-02STAA3.47-0.9214.55
2026-09-03STAA3.47-0.9214.55
2026-09-04STAA3.47-0.9214.55
2026-09-08STAA3.47-0.9114.55
2026-09-09STAA3.47-0.9114.55
2026-09-10STAA3.47-0.9114.55
2026-09-11STAA3.47-0.9114.13
2026-09-14STAA0.00-0.9314.06
2026-09-15STAA0.00-0.9314.06
2026-09-16STAA0.00-0.9314.06
2026-09-17STAA0.00-0.9314.06
2026-09-18STAA0.00-0.9314.06
2026-09-21STAA0.00-0.9414.06
2026-09-23STAA0.00-0.9414.06
2026-09-24STAA0.00-0.9414.06
2026-09-25STAA0.00-0.9415.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

0.18

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

Institutional Transactions

-0.94

Beta

1.19

Average Sales Estimate Current Quarter

79

Average Sales Estimate Next Quarter

68

Fair Value

Quality Score

50

Growth Score

67

Sentiment Score

21

Actual DrawDown %

85.5

Max Drawdown 5-Year %

-89.4

Target Price

27.89

P/E

308.42

Forward P/E

38

PEG

P/S

3.03

P/B

2.81

P/Free Cash Flow

EPS

0.07

Average EPS Est. Cur. Y​

0.76

EPS Next Y. (Est.)

1.02

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

1.13

Relative Volume

1.31

Return on Equity vs Sector %

-25.2

Return on Equity vs Industry %

-8.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ STAA Healthcare
$20.51
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
16/25
Volume
0/15
Valuation
15/20
TP/AR
2/10
Options
7/10
RSI
39.2
Range 1M
24.5%
Sup Dist
8.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
39 /100
WEAK
Momentum
0/25
Growth
24/30
Estimates
6/20
Inst/Vol
2/15
Options
7/10
EPS Yr
128.4%
EPS NY
90.1%
52W%
23.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +63.2% upside
Quality
9/30
Valuation
16/30
Growth
21/25
Stability
7/10
LT Trend
1/5
Upside
+63.2%
Quality
50
STAA — P/E HistoricalMedical Instruments & Supplies
STAAR Surgical Company
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 921
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAA

Latest News

—
Caricamento notizie per STAA…
stock quote shares STAA – STAAR Surgical Company Stock Price stock today
news today STAA – STAAR Surgical Company stock forecast ,stock prediction 2023 2024 2025
marketwatch STAA – STAAR Surgical Company yahoo finance google finance
stock history STAA – STAAR Surgical Company invest stock market
stock prices STAA premarket after hours
ticker STAA fair value insiders trading